Upgrade to SI Premium - Free Trial

Anebulo Pharmaceuticals, Inc. (ANEB) Reports Q1 Loss of $0.08

November 13, 2024 4:25 PM

Anebulo Pharmaceuticals, Inc. (NASDAQ: ANEB) reported Q1 EPS of ($0.08).

For earnings history and earnings-related data on Anebulo Pharmaceuticals, Inc. (ANEB) click here.

Categories

Earnings